AAAAAA
Results:
1-18
|
Results: 18
Authors:
Piccart, M
Cataliotti, L
Buchanan, M
Freilich, G
Jassem, J
Citation: M. Piccart et al., Brussels Statement document, EUR J CANC, 37(11), 2001, pp. 1335-1337
Authors:
Jassem, J
Ramlau, R
Karnicka-Mlodkowska, H
Krawczyk, K
Krzakowski, M
Zatloukal, P
Lemarie, E
Hartmann, W
Novakova, L
O'Brien, M
Depierre, A
Citation: J. Jassem et al., A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients, ANN ONCOL, 12(10), 2001, pp. 1375-1381
Authors:
Jassem, J
Pienkowski, T
Pluzanska, A
Jelic, S
Gorbunova, V
Mrsic-Krmpotic, Z
Berzins, J
Nagykalnai, T
Wigler, N
Renard, J
Munier, S
Weil, C
Citation: J. Jassem et al., Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial, J CL ONCOL, 19(6), 2001, pp. 1707-1715
Authors:
Jassem, J
Citation: J. Jassem, Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide for metastatic breast cancer - In reply, J CL ONCOL, 19(14), 2001, pp. 3441-3442
Authors:
Jassem, E
Bigda, J
Dziadziuszko, R
Schlichtholz, B
Le Roux, D
Grodzki, T
Rzyman, W
Konopa, K
Poberezna, MM
Dobrzanska, Z
Skokowski, J
Soussi, T
Jassem, J
Citation: E. Jassem et al., Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance, LUNG CANC, 31(1), 2001, pp. 17-23
Authors:
Serkies, K
Kobierska, A
Konopa, K
Sawicki, T
Jassem, J
Citation: K. Serkies et al., The feasibility study on continuous 7-day-a-week external beam irradiationin locally advanced cervical cancer: a report on acute toxicity, RADIOTH ONC, 61(2), 2001, pp. 197-202
Authors:
Serkies, K
Badzio, A
Jereczek-Fossa, B
Tarnawska, Z
Nowak, R
Szewczyk, P
Jassem, J
Citation: K. Serkies et al., Rectal doses in intracavitary brachytherapy of gynecological malignancies:comparison of two dosimetric methods, RADIOTH ONC, 58(1), 2001, pp. 37-41
Authors:
Klijn, JGM
Beex, LVAM
Mauriac, L
van Zijl, JA
Veyret, C
Wildiers, J
Jassem, J
Piccart, M
Burghouts, J
Becquart, D
Seynaeve, C
Mignolet, F
Duchateau, L
Citation: Jgm. Klijn et al., Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study, J NAT CANC, 92(11), 2000, pp. 903-911
Authors:
Blamey, R
Blichert-Toft, M
Cataliotti, L
Costa, A
Greco, M
Holland, R
Kaufmann, M
Perry, N
Ponti, A
Redmond, K
Sainsbury, R
van de Velde, C
Christiaens, M
Jassem, J
Julien, JP
Paridaens, R
Rutgers, E
van Limbergen, EF
Van den Bogaert, W
Vergote, I
Wildiers, J
Citation: R. Blamey et al., The requirements of a specialist breast unit, EUR J CANC, 36(18), 2000, pp. 2288-2293
Authors:
Jereczek-Fossa, B
Badzio, A
Jassem, J
Citation: B. Jereczek-fossa et al., Recurrent endometrial cancer after surgery alone: Results of salvage radiotherapy, INT J RAD O, 48(2), 2000, pp. 405-413
Authors:
Jassem, J
Skokowski, J
Dziadziuszko, R
Jassem, E
Szymanowska, A
Rzyman, W
Roszkiewicz, A
Citation: J. Jassem et al., Results of surgical treatment of non-small cell lung cancer: Validation ofthe new postoperative pathologic TNM classification, J THOR SURG, 119(6), 2000, pp. 1141-1146
Authors:
Senkus, E
Konefka, T
Nowaczyk, M
Jassem, J
Citation: E. Senkus et al., Second lower genital tract squamous cell carcinoma following cervical cancer - A clinical study of 46 patients, ACT OBST SC, 79(9), 2000, pp. 765-770
Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure
Authors:
Jereczek-Fossa, B
Badzio, A
Jassem, J
Citation: B. Jereczek-fossa et al., Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure, INT J GYN C, 9(4), 1999, pp. 285-294
Authors:
Jassem, J
Citation: J. Jassem, Chemotherapy of advanced non-small cell lung cancer, ANN ONCOL, 10, 1999, pp. 77-82
Authors:
Wysocka, B
Serkies, K
Debniak, J
Jassem, J
Limon, J
Citation: B. Wysocka et al., Sertoli cell tumor in androgen insensitivity syndrome - A case report, GYNECOL ONC, 75(3), 1999, pp. 480-483
Authors:
Serkies, K
Jereczek-Fossa, B
Badzio, A
Jassem, J
Citation: K. Serkies et al., Clodronate in the management of bone metastases: A clinical study of 91 patients, NEOPLASMA, 46(5), 1999, pp. 317-322
Authors:
Bartelink, H
Van Der Schueren, E
Budach, V
Bernier, J
Horwich, A
Jancar, B
Roth, S
Landmann, C
Jassem, J
Khoury, G
Storme, G
Cosset, JM
Batterman, J
Van Den Weijngaert, D
Hamers, HP
Renaud, A
Van Houtte, P
Cionini, L
Horiot, JC
Schraub, S
Nguyen, TD
Eschwege, F
Bolla, M
Sylvestre, ME
Gerard, JP
de Vilhena, M
Levendag, PC
Leer, JW
Sola, AB
Mirimanoff, RO
Pourquier, H
Bey, P
Le Fur, R
Calitchi, E
Lefloch, O
Monpetit, E
Gonzalez, D
Kurtz, JM
Meerwaldt, JH
Johansson, KA
Van Daal, W
Jager, JJ
Muller, RP
Citation: H. Bartelink et al., Assessment of the impact of improved local control by radiotherapy on survival in cancer patients, BIOM HLTH R, 24, 1998, pp. 370-374
Authors:
Zatloukal, P
Kanitz, E
Magyar, P
Jassem, J
Krzakowski, M
Pawlicki, M
Petruzelka, L
Chovan, L
Pesek, M
Janko, C
Krejcy, K
Citation: P. Zatloukal et al., Gemcitabine in locally advanced and metastatic non-small cell lung cancer:The Central European phase II study, LUNG CANC, 22(3), 1998, pp. 243-250
Risultati:
1-18
|